Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT - Google Search

table,div,span,p{display:none}Please click here if you are not redirected within a few seconds.

All Images NewsVideos Maps Shopping Books

Any duration

Any time

Any quality

Any quality
High quality

All videos

All videos
Closed captioned

Any source

EBMT 2018 | Rituximab-based first line treatment for cGvHD after allogeneic SCT - YouTube

www.youtube.com › watch

Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT from www.youtube.com

Mar 20, 2018 � 44th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT ...
Duration: 1:50
Posted: Mar 20, 2018

The Future of Hematopoietic Stem Cell Transplantation (HSCT) - 2024 Blood Cancer OncTalk - YouTube

www.youtube.com › watch

Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT from www.youtube.com

Nov 26, 2024 � ... Transplantation (HSCT) in fields such as Leukemia, MDS, Multiple Myeloma, Non-Hodgkin ...
Duration: 4:49
Posted: Nov 26, 2024

The 46 th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians Poster Session (P001-P706) – ScienceOpen

www.scienceopen.com › document

Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT from www.scienceopen.com

Posted: Mar 16, 2021